Femara® 2.5 mg NOVARTIS: What Is It?

Femara® 2.5 mg is a medication manufactured by NOVARTIS that is commonly used in the treatment of breast cancer in postmenopausal Femara® 2,5 mg NOVARTIS buy women. This medication contains the active ingredient Letrozole, which belongs to a class of drugs known as aromatase inhibitors.

How Does Femara® Work?

Femara® 2.5 mg works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogen. By blocking this process, Femara® helps lower the levels of estrogen in the body, which can slow down or even stop the growth of hormone receptor-positive breast cancer cells.

Who Can Benefit from Femara® 2.5 mg?

Femara® 2.5 mg is typically prescribed for postmenopausal women who have been diagnosed with hormone receptor-positive breast cancer. It may be used alone as adjuvant treatment after surgery or in combination with other medications for advanced or metastatic breast cancer.

It is important to follow your healthcare provider’s instructions carefully when taking Femara® 2.5 mg to ensure the best possible outcomes and minimize potential side effects.

If you have any questions or concerns about Femara® 2.5 mg NOVARTIS, be sure to discuss them with your healthcare provider before starting this medication.